explore -WSS

explore

author：leisure time 2025-09-29 16:35:17 - browse：321

Illustration of a teal cancer cell. -- health coverage from STAT — Illustration of a teal cancer cell. Adobe

Sana Biotechnology, a startup that just a couple of years ago raised over $1 billion off a grand plan to create a portfolio of powerful medicines, said Tuesday it would lay off nearly a third of its employees and de-prioritize one of its most ambitious programs as it looks to save money.

The layoffs are Sana’s second round of cuts in less than a year. It laid off 15% of staff last November after axing another program.

Tuesday’s move pushed back a program focused on turning a patient’s own immune cells into cancer-killing assassins or curing blood disorders such as sickle cell with just an IV infusion. Known as in vivo reprogramming, it was originally the company’s central focus and would have amounted to a monumental breakthrough.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： How CO2 helps viruses stay alive longer in the air

knowledge

WSS

At least 12 people were injured in a blast at a port in northwest Turkey

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Elevance PBM president out as customers face prescription chaos

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Illumina board agrees to spin off Grail, as divestment plans proceed

knowledge

explore

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

CMS got Medicare Advantage quality rating wrong, judge rules

Bright Health sells Medicare Advantage business to Molina

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Heart attack and stroke risk calculators need revising

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Virginia high school admissions case could be legal follow

Elevance PBM president out as customers face prescription chaos

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Fight over Supreme Court dialysis ruling puts kidney patients at risk

leisure time

Democratic lawmaker calls for 'well

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

The most pressing bird flu mysteries scientists want answered

Mississippi candidates for statewide offices square off in party primaries

For pregnant people, addiction treatment shouldn't mean a call to child protective services

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

hotspot

knowledge

focus

knowledge